PL2931922T3 - Personalizowane biomarkery nowotworu - Google Patents
Personalizowane biomarkery nowotworuInfo
- Publication number
- PL2931922T3 PL2931922T3 PL13863107T PL13863107T PL2931922T3 PL 2931922 T3 PL2931922 T3 PL 2931922T3 PL 13863107 T PL13863107 T PL 13863107T PL 13863107 T PL13863107 T PL 13863107T PL 2931922 T3 PL2931922 T3 PL 2931922T3
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- personalized biomarkers
- biomarkers
- personalized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737626P | 2012-12-14 | 2012-12-14 | |
| EP13863107.2A EP2931922B1 (en) | 2012-12-14 | 2013-12-13 | Personalized biomarkers for cancer |
| PCT/US2013/075015 WO2014093825A1 (en) | 2012-12-14 | 2013-12-13 | Personalized biomarkers for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2931922T3 true PL2931922T3 (pl) | 2019-04-30 |
Family
ID=50934991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13863107T PL2931922T3 (pl) | 2012-12-14 | 2013-12-13 | Personalizowane biomarkery nowotworu |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9909186B2 (pl) |
| EP (1) | EP2931922B1 (pl) |
| ES (1) | ES2703764T3 (pl) |
| PL (1) | PL2931922T3 (pl) |
| WO (1) | WO2014093825A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014113204A1 (en) | 2013-01-17 | 2014-07-24 | Personalis, Inc. | Methods and systems for genetic analysis |
| EP3965111A1 (en) | 2013-08-30 | 2022-03-09 | Personalis, Inc. | Methods and systems for genomic analysis |
| WO2015051275A1 (en) | 2013-10-03 | 2015-04-09 | Personalis, Inc. | Methods for analyzing genotypes |
| JP7441584B6 (ja) * | 2014-08-22 | 2024-03-15 | レゾリューション バイオサイエンス， インコーポレイテッド | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
| EP4026913A1 (en) | 2014-10-30 | 2022-07-13 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| WO2017066785A1 (en) * | 2015-10-16 | 2017-04-20 | The Regents Of The University Of California, A California Corporation | Repetitive element (re)-based genome analysis and dynamic genetics surveillance systems |
| WO2017083562A1 (en) | 2015-11-11 | 2017-05-18 | Resolution Bioscience, Inc. | High efficiency construction of dna libraries |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| KR102505122B1 (ko) | 2016-08-25 | 2023-03-08 | 레졸루션 바이오사이언스, 인크. | Dna 샘플 중 게놈 카피 변화의 검출을 위한 방법 |
| EP3541950A4 (en) * | 2016-11-16 | 2020-06-03 | Progenity, Inc. | MULTIMODAL ASSAY FOR THE DETECTION OF NUCLEIC ACID ABERRATIONS |
| US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| WO2020168239A1 (en) * | 2019-02-15 | 2020-08-20 | Takara Bio Usa, Inc. | Methods of preparing and analyzing nucleic acid libraries |
| CN109825583B (zh) * | 2019-03-01 | 2021-08-17 | 清华大学 | 人重复元件dna甲基化作为肝癌早期诊断的标记物及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955589A (en) | 1991-12-24 | 1999-09-21 | Isis Pharmaceuticals Inc. | Gapped 2' modified oligonucleotides |
| YU187991A (sh) | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba |
| US5652099A (en) | 1992-02-12 | 1997-07-29 | Conrad; Michael J. | Probes comprising fluorescent nucleosides and uses thereof |
| US5446137B1 (en) | 1993-12-09 | 1998-10-06 | Behringwerke Ag | Oligonucleotides containing 4'-substituted nucleotides |
| DE4415370A1 (de) | 1994-05-02 | 1995-11-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| DE4438918A1 (de) | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| US5773649A (en) * | 1996-06-10 | 1998-06-30 | Centre De Recherche De L'hopital Sainte-Justine | DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells |
| US6344317B2 (en) * | 1996-10-04 | 2002-02-05 | Chronix Biomedical, Inc. | Diagnostic detection of nucleic acids |
| ATE280177T1 (de) | 1997-03-20 | 2004-11-15 | Hoffmann La Roche | Modifizierte primer |
| USH2191H1 (en) * | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| US20070231823A1 (en) * | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
| US8986958B2 (en) * | 2009-03-30 | 2015-03-24 | Life Technologies Corporation | Methods for generating target specific probes for solution based capture |
| CN102409048B (zh) * | 2010-09-21 | 2013-10-23 | 深圳华大基因科技服务有限公司 | 一种基于高通量测序的dna标签文库构建方法 |
| WO2012129008A1 (en) * | 2011-03-18 | 2012-09-27 | Baylor Research Institute | Line-1 hypomethylation as a biomarker for early-onset colorectal cancer |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| CA2888520A1 (en) * | 2012-10-19 | 2014-04-24 | Sequenta, Inc. | Monitoring diffuse large b-cell lymphoma from peripheral blood samples |
-
2013
- 2013-12-13 PL PL13863107T patent/PL2931922T3/pl unknown
- 2013-12-13 US US14/652,098 patent/US9909186B2/en active Active
- 2013-12-13 ES ES13863107T patent/ES2703764T3/es active Active
- 2013-12-13 WO PCT/US2013/075015 patent/WO2014093825A1/en active Application Filing
- 2013-12-13 EP EP13863107.2A patent/EP2931922B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2703764T3 (es) | 2019-03-12 |
| EP2931922A4 (en) | 2016-07-27 |
| US9909186B2 (en) | 2018-03-06 |
| EP2931922A1 (en) | 2015-10-21 |
| EP2931922B1 (en) | 2018-10-17 |
| WO2014093825A1 (en) | 2014-06-19 |
| US20160053328A1 (en) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1210832A1 (en) | Cancer diagnostics using biomarkers | |
| HK1217218A1 (zh) | 結直腸癌生物標誌物 | |
| PL2931922T3 (pl) | Personalizowane biomarkery nowotworu | |
| EP2825674A4 (en) | BIOMARKER FOR THYROID CANCER | |
| EP2536854A4 (en) | CUSTOMIZED TUMOR BIOMARKERS | |
| EP2718721A4 (en) | CIRCULATING BIOMARKERS FOR CANCER | |
| HK1193637A1 (en) | Biomarkers for lung cancer | |
| GB201213567D0 (en) | Biomarkers | |
| HK1206414A1 (en) | Biomarkers for gastric cancer and uses thereof | |
| EP2698634A4 (en) | BIOMARKER FOR BREAST CANCER | |
| IL233803A0 (en) | Monocyte biomarkers for cancer detection | |
| HK1226106A1 (zh) | 針對膀胱癌的dna甲基化生物標誌物 | |
| GB201211982D0 (en) | Biomarker | |
| EP2831270B8 (en) | Biomarker for bladder cancer | |
| EP2876447A4 (en) | METHOD OF DETECTING CANCER | |
| EP2876446A4 (en) | METHOD OF DETECTING CANCER | |
| HK1216779A1 (zh) | 用於癌症治療的預測性生物標記物 | |
| HK1224010A1 (zh) | 卵巢癌生物標誌物 | |
| EP2861766A4 (en) | METHYLATION BIOMARKERS FOR BREAST CANCER | |
| EP2828282A4 (en) | BIOMARKERS | |
| HK1202899A1 (en) | Biomarkers for diabetes | |
| GB201210565D0 (en) | Biomarkers | |
| EP2894477A4 (en) | METHOD FOR DETECTION OF BREAST CANCER | |
| EP2864782A4 (en) | BIOMARKERS OF DEMENTIA WITH NEUROFIBRILLARY DEGENERATION | |
| GB201209802D0 (en) | Biomarker |